Thorben Höltkemeier is part of the Drug Product Development unit of Novartis Pharma AG in Basel, Switzerland and part of the Structure Biophysics Stability experts team focusing on modelling and simulation approaches. In his six years at Novartis he gained experience in the small molecule world and has pursued a PhD on chemical stability of biopharmaceutics in collaboration with LMU Munich, Germany. Before joining Novartis Thorben received a bachelor’s and master’s degree in biotechnology with a focus on bioprocess engineering from the technical university of Braunschweig, Germany.